Literature DB >> 27015778

Safety Considerations and Monitoring in Patients Treated with Systemic Medications for Acne.

Hyunhee Park1, Stanley Skopit2.   

Abstract

Acne vulgaris, a disorder of the pilosebaceous unit, is one of the most commonly encountered conditions in dermatology practice. Effective treatment of acne vulgaris is important in that it can prevent psychosocial distress and physical scarring. Systemic therapeutic options are available for moderate to severe acne. It is imperative that the safe and effective treatment revolves around the health care provider's familiarity of side effects of various treatments. In this article, the side effects and monitoring guide for the most commonly prescribed systemic agents for acne vulgaris are reviewed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acne; Isotretinoin; Monitoring; Oral antibiotics; Safety; Spironolactone; Systemic treatments

Mesh:

Substances:

Year:  2016        PMID: 27015778     DOI: 10.1016/j.det.2015.11.004

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  2 in total

1.  Topical Treatment of Human Skin and Cultured Keratinocytes with High-Dose Spironolactone Reduces XPB Expression and Induces Toxicity.

Authors:  M Alexandra Carpenter; Michael G Kemp
Journal:  JID Innov       Date:  2021-05-06

Review 2.  Spironolactone and XPB: An Old Drug with a New Molecular Target.

Authors:  Ryan D Gabbard; Robert R Hoopes; Michael G Kemp
Journal:  Biomolecules       Date:  2020-05-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.